Filter Results:
(722)
Show Results For
- All HBS Web
(722)
- News (85)
- Research (556)
- Events (3)
- Multimedia (8)
- Faculty Publications (477)
Show Results For
- All HBS Web
(722)
- News (85)
- Research (556)
- Events (3)
- Multimedia (8)
- Faculty Publications (477)
- January 1980 (Revised September 1988)
- Case
Germany (A): The Rebirth of an Economy
Anderson, Douglas D. "Germany (A): The Rebirth of an Economy." Harvard Business School Case 380-120, January 1980. (Revised September 1988.)
- 2025
- Working Paper
Threat and Assimilation: Evidence from Refugees in Germany
By: Philipp Jaschke, Sulin Sardoschau and Marco Tabellini
This paper studies the effects of local threat on the cultural assimilation and economic integration of refugees, exploiting plausibly exogenous variation in their allocation across German regions between 2013 and 2016. We use representative survey data and... View Details
Keywords: Assimilation; Threat Hypothesis; Migration; Cultural Change; Refugees; Culture; Identity; Germany
Jaschke, Philipp, Sulin Sardoschau, and Marco Tabellini. "Threat and Assimilation: Evidence from Refugees in Germany." Harvard Business School Working Paper, No. 22-043, December 2021. (Revised January 2025. Revise and resubmit at the Economic Journal. Also available from NBER, and featured on Le Monde.)
- 11 Sep 2019
- Research & Ideas
Germany May Have the Answer for Reducing Drug Prices
American lawmakers attempting to stem spiraling drug costs might find inspiration in Germany, where the government’s regulatory model has been curbing price growth without thwarting innovation or access, says research from Harvard Business School. Since 2011, View Details
- August 2022
- Article
Availability of New Medicines in the U.S. and Germany From 2004 to 2018
By: Katharina Blankart, Huseyin Naci and Amitabh Chandra
Importance: Germany's unique approach to coverage determination and pricing has ensured that effective medicines remain on the market, often at prices reduced through negotiation. However, less is known about trade-offs of this approach with regard to initial... View Details
Keywords: Market Entry and Exit; Price; Market Timing; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; United States; Germany
Blankart, Katharina, Huseyin Naci, and Amitabh Chandra. "Availability of New Medicines in the U.S. and Germany From 2004 to 2018." e2229231. JAMA Network Open 5, no. 8 (August 2022).
- February 1993 (Revised April 1993)
- Teaching Note
Germany in the 1990s: Managing Reunification and Supplement TN
By: George C. Lodge
Teaching Note for (9-793-033) and (9-793-042). View Details
- 2004
- Book
Pharmacopolitics: Drug Regulation in the United States and Germany
By: Arthur A. Daemmrich
Keywords: Health; Governing Rules, Regulations, and Reforms; Government and Politics; United States; Germany
Daemmrich, Arthur A. Pharmacopolitics: Drug Regulation in the United States and Germany. University of North Carolina Press, 2004. (Winner of Edward Kremers Award of the American Institute of the History of Pharmacy For best book in pharmaco-historical writing published in the previous two years presented by American Institute of the History of Pharmacy.)
- 09 Sep 2015
- News
Here's why Germany is welcoming migrants with open arms
- January 2006 (Revised April 2006)
- Supplement
Dr. Ing. h.c. F. Porsche AG (B): Made in Germany
By: Jeffrey Fear and Carin-Isabel Knoop
Fear, Jeffrey, and Carin-Isabel Knoop. "Dr. Ing. h.c. F. Porsche AG (B): Made in Germany." Harvard Business School Supplement 706-019, January 2006. (Revised April 2006.)
- March 1996
- Case
Germany and the Bonn-Berlin Split: Supporting Distributed Work Through IT
By: Lynda M. Applegate and Carin-Isabel Knoop
Applegate, Lynda M., and Carin-Isabel Knoop. "Germany and the Bonn-Berlin Split: Supporting Distributed Work Through IT." Harvard Business School Case 396-169, March 1996.
- 08 Jul 2019
- News
What the U.S. can learn from Germany on drug prices
- 2022
- Book
Empires of Ideas: Creating the Modern University from Germany to America to China
By: William C. Kirby
The modern university was born in Germany. In the twentieth century, the United States leapfrogged Germany to become the global leader in higher education. Will China challenge its position in the twenty-first?
Today American institutions dominate nearly every... View Details
Today American institutions dominate nearly every... View Details
Kirby, William C. Empires of Ideas: Creating the Modern University from Germany to America to China. Cambridge, MA: Belknap Press of Harvard University Press, 2022.
- May 1980 (Revised July 1980)
- Case
Germany (B): The Uncertain Stride of a Reluctant Giant
Anderson, Douglas D. "Germany (B): The Uncertain Stride of a Reluctant Giant." Harvard Business School Case 380-121, May 1980. (Revised July 1980.)
- 19 Jul 2019
- News
Can Germany help the U.S. lower prescription drug prices?
- summer 1992
- Article
Governance, Contracting, and Investment Time Horizons: A Look at Japan and Germany
By: W. C. Kester
Kester, W. C. "Governance, Contracting, and Investment Time Horizons: A Look at Japan and Germany." Continental Bank Journal of Applied Corporate Finance 5, no. 2 (summer 1992): 83–98.
- 2003
- Chapter
Regulatory Laws and Political Culture in the United States and Germany
By: Arthur A. Daemmrich
- July 2020
- Article
Lessons from the Impact of Price Regulation on the Pricing of Anticancer Drugs in Germany
By: Victoria D. Lauenroth, Aaron S. Kesselheim, Ameet Sarpatwari and Ariel Dora Stern
Worldwide spending on prescription drugs has increased dramatically in recent years. Although this increase has been particularly pronounced in the U.S., it remains largely unaddressed there. In Europe, however, different approaches to regulating drug prices have been... View Details
Keywords: Pharmaceuticals; Prescription Drug Costs; Drug Pricing; Access To Care; Cost Reduction; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Cost Management; Germany
Lauenroth, Victoria D., Aaron S. Kesselheim, Ameet Sarpatwari, and Ariel Dora Stern. "Lessons from the Impact of Price Regulation on the Pricing of Anticancer Drugs in Germany." Health Affairs 39, no. 7 (July 2020): 1185–1193.
- October 1991 (Revised December 1992)
- Background Note
Note on Corporate Governance Systems: The United States, Japan, and Germany
By: W. Carl Kester and Robert W. Lightfoot
Describes and compares the corporate governance systems commonly found in the United States, Japan, and Germany. View Details
Kester, W. Carl, and Robert W. Lightfoot. "Note on Corporate Governance Systems: The United States, Japan, and Germany." Harvard Business School Background Note 292-012, October 1991. (Revised December 1992.)
- 2006
- Book
Consumer Capitalism: Politics, Product Markets, and Firm Strategy in France and Germany
By: Gunnar Trumbull
Trumbull, Gunnar. Consumer Capitalism: Politics, Product Markets, and Firm Strategy in France and Germany. Ithaca: Cornell University Press, 2006.